Zahra Shahraki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zahra Shahraki has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Mahsa Ghajarzadeh
Multiple Sclerosis Research Group (MSRG),Universal Scientific Education and Research Network (USERN),Tehran University of Medical Sciences, Tehran, Iran
3 shared publicationsMarjan Ghaemi
Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences, Tehran, Iran
2 shared publicationsAli Zarrinnia
Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationArman Golsefat
Department of Obstetrics and Gynecology , Zabol University of Medical Sciences , Zabol , Iran
1 shared publicationBatool Shahraki Mojahed
Zabol University of Medial Sciences, Zabol, Iran
1 shared publicationFariba Askari
Reproductive Health and Population Research Center, Gonabad University of Medical Sciences, Gonabad, Iran
1 shared publication
Latest Publications
- 15 December 2024
- Published by TARUS Media in Mædica
- Vol. 19 (4) , 823-828
Pregnancy Outcomes in Women with Multiple Sclerosis Who Had Exposure to Ocrelizumab: a Systematic Review of the Literature
Objective: To estimate the pooled prevalence of pregnancy-related issues in women who were exposed to Ocrelizumab before or during pregnancy.
- 15 December 2024
- Published by TARUS Media in Mædica
- Vol. 19 (4) , 823-828
Pregnancy Outcomes in Women with Multiple Sclerosis Who Had Exposure to Ocrelizumab: a Systematic Review of the Literature
Objective: To estimate the pooled prevalence of pregnancy-related issues in women who were exposed to Ocrelizumab before or during pregnancy.
- Open Access
- 1 January 2024
- Published by Wiley in Andrologia
- Vol. 2024 (1)
Mood Disorders and Sexual Function in Infertile Men: Exploring the Relationship with Semen Analysis Results
Objective. The presence of infertility in couples not only results in heightened stress but also elevates the risk of developing psychological disorders, further exacerbating their situation. This study is designed to evaluate the relationship between semen analysis and depression, anxiety, and stress, as well as sexual function in infertile men. Method. This descriptive cross‐sectional study was carried out at Amir Al‐Momenin Hospital of Zabol between March 2019 and April 2020. The couples who were candidates for intracytoplasmic sperm injection according to male factors were recruited for the study. One hundered two men were asked to complete the depression, anxiety, and stress questionnaire (DASS‐42) and the International Index of Erectile Function questionnaire (IIEF‐15). The findings of the DASS and IIEF questionnaires were compared with the semen analysis test and reported. Results. The frequency of depression, anxiety, and moderate to very severe stress were found in 21 (20.6%), 40 (39.2%), and 23 (22.5%) cases, respectively. Surprisingly, 60 (59%) participants had erectile dysfunction. A significant correlation was found between mood disorders (depression, anxiety, and stress) and some components of the erectile function questionnaire, stress with erectile function (p = 0.045), depression with overall satisfaction (p = 0.011), and anxiety with intercourse satisfaction (p = 0.048) and overall satisfaction (p = 0.037). Also, there was a significant correlation between semen analysis parameters such as sperm motility with depression (p = 0.035) and anxiety (p = 0.037), normal sperm morphology with stress (p = 0.034), progressive sperm motility with orgasmic function (p = 0.006), and intercourse satisfaction (p = 0.014). Conclusion. The higher the mental health, the higher the erectile function. Improvement of mood disorders leads to improvement of semen parameters and increases the chances of pregnancy. Psychological support may be helpful so, in addition to medical treatment, these people should also receive supportive psychological treatment.
- 1 January 2024
- Published by Wiley in Andrologia
- Vol. 2024 (1)
Open AccessMood Disorders and Sexual Function in Infertile Men: Exploring the Relationship with Semen Analysis Results
Objective. The presence of infertility in couples not only results in heightened stress but also elevates the risk of developing psychological disorders, further exacerbating their situation. This study is designed to evaluate the relationship between semen analysis and depression, anxiety, and stress, as well as sexual function in infertile men. Method. This descriptive cross‐sectional study was carried out at Amir Al‐Momenin Hospital of Zabol between March 2019 and April 2020. The couples who were candidates for intracytoplasmic sperm injection according to male factors were recruited for the study. One hundered two men were asked to complete the depression, anxiety, and stress questionnaire (DASS‐42) and the International Index of Erectile Function questionnaire (IIEF‐15). The findings of the DASS and IIEF questionnaires were compared with the semen analysis test and reported. Results. The frequency of depression, anxiety, and moderate to very severe stress were found in 21 (20.6%), 40 (39.2%), and 23 (22.5%) cases, respectively. Surprisingly, 60 (59%) participants had erectile dysfunction. A significant correlation was found between mood disorders (depression, anxiety, and stress) and some components of the erectile function questionnaire, stress with erectile function (p = 0.045), depression with overall satisfaction (p = 0.011), and anxiety with intercourse satisfaction (p = 0.048) and overall satisfaction (p = 0.037). Also, there was a significant correlation between semen analysis parameters such as sperm motility with depression (p = 0.035) and anxiety (p = 0.037), normal sperm morphology with stress (p = 0.034), progressive sperm motility with orgasmic function (p = 0.006), and intercourse satisfaction (p = 0.014). Conclusion. The higher the mental health, the higher the erectile function. Improvement of mood disorders leads to improvement of semen parameters and increases the chances of pregnancy. Psychological support may be helpful so, in addition to medical treatment, these people should also receive supportive psychological treatment.
- Open Access
- 30 May 2023
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 16 (1) , 105
Depression, sexual function and sexual quality of life in women with polycystic ovary syndrome (PCOS) and healthy subjects
Background: Women with polycystic ovary syndrome (PCOS) suffer from a wide range of psychological problems. The goal of this study is to assess depression, sexual dysfunction and sexual quality of life in women with PCO compared with healthy subjects. Methods: One hundred and six PCO cases and 106 healthy subjects enrolled. They were asked to fill out valid and reliable Persian versions of BDI (Beck depression inventory), FSFIS (Female Sexual Function Index), and sexual quality of life-Female (SQOL-F) questionnaires. Results: One hundred and six PCO cases and 106 healthy subjects enrolled. Mean BDI was significantly higher while FSFI and its subscales as well as SQOL-F were significantly lower in PCO group than controls. There were significant negative correlation between FSFO and BDI (r=-0.43, p < 0.001) and also positive correlation between FSFI and SQOL-F (r = 0.438, p < 0.001) in whole population of the study. In PCO group, 77 (72.6%) had FSFI less than 26.55 and 29 (27.4%) had score more than 26.55. mean BDI was significantly higher in the group with FSFI < = 26.55 than the other group (33 ± 14.4 vs. 12 ± 11.6, p < 0.001) while SLQL-F was significantly lower in the first group (57 ± 16 vs. 74.9 ± 17.6, p < 0.001). Linear regression analysis by considering SQOL-F as dependent and FSFI, age and BDI as independent variables showed that BDI and FSFI are independent predictors. Conclusion: Women with PCO, suffer more from depression and sexual dysfunction than healthy subjects.
- 30 May 2023
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 16 (1) , 105
Open AccessDepression, sexual function and sexual quality of life in women with polycystic ovary syndrome (PCOS) and healthy subjects
Background: Women with polycystic ovary syndrome (PCOS) suffer from a wide range of psychological problems. The goal of this study is to assess depression, sexual dysfunction and sexual quality of life in women with PCO compared with healthy subjects. Methods: One hundred and six PCO cases and 106 healthy subjects enrolled. They were asked to fill out valid and reliable Persian versions of BDI (Beck depression inventory), FSFIS (Female Sexual Function Index), and sexual quality of life-Female (SQOL-F) questionnaires. Results: One hundred and six PCO cases and 106 healthy subjects enrolled. Mean BDI was significantly higher while FSFI and its subscales as well as SQOL-F were significantly lower in PCO group than controls. There were significant negative correlation between FSFO and BDI (r=-0.43, p < 0.001) and also positive correlation between FSFI and SQOL-F (r = 0.438, p < 0.001) in whole population of the study. In PCO group, 77 (72.6%) had FSFI less than 26.55 and 29 (27.4%) had score more than 26.55. mean BDI was significantly higher in the group with FSFI < = 26.55 than the other group (33 ± 14.4 vs. 12 ± 11.6, p < 0.001) while SLQL-F was significantly lower in the first group (57 ± 16 vs. 74.9 ± 17.6, p < 0.001). Linear regression analysis by considering SQOL-F as dependent and FSFI, age and BDI as independent variables showed that BDI and FSFI are independent predictors. Conclusion: Women with PCO, suffer more from depression and sexual dysfunction than healthy subjects.
- Open Access
- 29 November 2021
- Published by Knowledge E DMCC in Journal of Family & Reproductive Health
- Vol. 15 (4) , 248-251
Effect of Two Different Doses of Vitamin D Supplementation on Uterine Myoma on South East Iranian Population; A Clinical Trial
Objective: Uterine myoma is the most common benign tumor however with significant distress and reduced quality of life in affected women. Besides, vitamin D deficiency may be a risk factor for uterine myoma. This study aimed to evaluate the effect of vitamin D supplements on the size of myoma in women with vitamin D insufficiency or deficiency. Materials and methods: This clinical trial was conducted in a teaching hospital from 2019 to 2020. According to baseline vitamin D level, participants were assigned into two interventional equal groups (vitamin D deficiency or insufficiency) to receive either 1000 IU daily or 50000 IU weekly vitamin D for 12 weeks. The size and location of the uterine myoma were compared before and after the intervention. Results: Totally, 137 women with uterine myoma were enrolled. Based on baseline vitamin D level, 52 cases had vitamin D insufficiency and 85 cases had vitamin D deficiency. No significant difference was observed in age and BMI in both groups. The location of the subserosal and intramural myoma did not differ, otherwise, the percent of the submucosal myomas were increased significantly (p=0.020) after the intervention. In both groups decreased myoma size otherwise not significant was seen after the intervention (p=0.148 and p=0.664 respectively). Conclusion: Vitamin D supplementation may not be effective in women with vitamin D insufficiency or deficiency in the short term to reduce myoma size.
- 29 November 2021
- Published by Knowledge E DMCC in Journal of Family & Reproductive Health
- Vol. 15 (4) , 248-251
Open AccessEffect of Two Different Doses of Vitamin D Supplementation on Uterine Myoma on South East Iranian Population; A Clinical Trial
Objective: Uterine myoma is the most common benign tumor however with significant distress and reduced quality of life in affected women. Besides, vitamin D deficiency may be a risk factor for uterine myoma. This study aimed to evaluate the effect of vitamin D supplements on the size of myoma in women with vitamin D insufficiency or deficiency. Materials and methods: This clinical trial was conducted in a teaching hospital from 2019 to 2020. According to baseline vitamin D level, participants were assigned into two interventional equal groups (vitamin D deficiency or insufficiency) to receive either 1000 IU daily or 50000 IU weekly vitamin D for 12 weeks. The size and location of the uterine myoma were compared before and after the intervention. Results: Totally, 137 women with uterine myoma were enrolled. Based on baseline vitamin D level, 52 cases had vitamin D insufficiency and 85 cases had vitamin D deficiency. No significant difference was observed in age and BMI in both groups. The location of the subserosal and intramural myoma did not differ, otherwise, the percent of the submucosal myomas were increased significantly (p=0.020) after the intervention. In both groups decreased myoma size otherwise not significant was seen after the intervention (p=0.148 and p=0.664 respectively). Conclusion: Vitamin D supplementation may not be effective in women with vitamin D insufficiency or deficiency in the short term to reduce myoma size.
- 2 August 2021
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 50 (1) , 108-109
Anxiety and fear in pregnant women of being infected by COVID-19 in new Delta pandemic
Article Anxiety and fear in pregnant women of being infected by COVID-19 in new Delta pandemic was published on January 1, 2022 in the journal Journal of Perinatal Medicine (volume 50, issue 1).
- 2 August 2021
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 50 (1) , 108-109
Anxiety and fear in pregnant women of being infected by COVID-19 in new Delta pandemic
Article Anxiety and fear in pregnant women of being infected by COVID-19 in new Delta pandemic was published on January 1, 2022 in the journal Journal of Perinatal Medicine (volume 50, issue 1).
- Open Access
- 14 June 2018
- Published by Springer Nature in BMC Women's Health
- Vol. 18 (1) , 1-4
Depression, sexual dysfunction and sexual quality of life in women with infertility
Women suffering from infertility are at higher risk of experiencing psychological problems. Sexual function and sexual related quality of life is not considered as it should be. We designed this study to assess depression, sexual function and sexual quality of life in Iranian women with infertility. Two hundred and sixty four individuals participated in the study (115 healthy controls, 78 with primary and 71 with secondary infertility). All participants were asked to fill a valid and reliable Persian versions of BDI (Beck depression inventory), FSFIS (Female Sexual Function Index) and sexual quality of life-Female (SQOL-F) questionnaires. Mean BDI score was significantly lower in healthy individuals.Individuals with primary infertility suffered more from sexual dysfunction, while BDI score was significantly higher and SQOL-F was significantly lower in cases with sexual dysfunction. There was significant positive correlation between SQOL-F and total FSFI score (r = 0.59, p < 0.001). Linear regression analysis by considering SQOL-F as dependent and age, BDI, duration of marriage, sexual dysfunction (FSFI ≤26.55 or > 26.55) showed that BDI and sexual dysfunction were independent predictors of SQOL-F. Sexual function and quality of life related to sexual life should be considered in Iranian infertile ones. Depression as a crucial factor should be focused more in infertile women.
- 14 June 2018
- Published by Springer Nature in BMC Women's Health
- Vol. 18 (1) , 1-4
Open AccessDepression, sexual dysfunction and sexual quality of life in women with infertility
Women suffering from infertility are at higher risk of experiencing psychological problems. Sexual function and sexual related quality of life is not considered as it should be. We designed this study to assess depression, sexual function and sexual quality of life in Iranian women with infertility. Two hundred and sixty four individuals participated in the study (115 healthy controls, 78 with primary and 71 with secondary infertility). All participants were asked to fill a valid and reliable Persian versions of BDI (Beck depression inventory), FSFIS (Female Sexual Function Index) and sexual quality of life-Female (SQOL-F) questionnaires. Mean BDI score was significantly lower in healthy individuals.Individuals with primary infertility suffered more from sexual dysfunction, while BDI score was significantly higher and SQOL-F was significantly lower in cases with sexual dysfunction. There was significant positive correlation between SQOL-F and total FSFI score (r = 0.59, p < 0.001). Linear regression analysis by considering SQOL-F as dependent and age, BDI, duration of marriage, sexual dysfunction (FSFI ≤26.55 or > 26.55) showed that BDI and sexual dysfunction were independent predictors of SQOL-F. Sexual function and quality of life related to sexual life should be considered in Iranian infertile ones. Depression as a crucial factor should be focused more in infertile women.
- Open Access
- 14 September 2016
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 7 (4)
Comparing Neonatal Outcome Following the Use of Ondansetron versus Vitamin B6 in Pregnant Females with Morning Sickness: A Randomized Clinical Trial
Background: Pregnancy-related nausea and vomiting or morning sickness with an overall prevalence rate of 80% is commonly appeared at the eighth week and frequently disappeared in most pregnant females at the 16th week of gestation. The severe form of the condition named hyperemesis occurs in one per 200 to 300 pregnancies; it is accompanied by dehydration, electrolyte instability and nutritional deficits and needs medical interventions. Limited data are available on harmful effects of common antiemetic medications used within pregnancy on human neonates. Objectives: The current study aimed to compare the effects of ondansetron and vitamin B6 on neonatal outcome in pregnant females with pregnancy-related nausea and vomiting. Neonatal outcome included the probable difference in neonates’ gestational age, weight, height, head circumference and frequency of apparent congenital anomalies. Methods: This randomized double-blinded clinical trial was conducted on 188 primipara singleton pregnant females with pregnancy-related nausea and vomiting who referred to state healthcare centers of Zabol, Iran, in 2014. The pregnant females were randomly assigned to receive drug packages including ondansetron tablets (4 mg) or vitamin B6 tablets (40 mg) and patients were instructed to take one tablet twice daily. Females were followed up until delivery and neonatal outcomes including any congenital anomaly, weight, height and head circumference at birth were assessed. Results: There was no difference between the groups in the mean age of mother and the mean age of gestation. No differences were found between the groups regarding birth weight (3006.93 ± 441.86 versus 2949.65 ± 457.36 g, P= 0.67), height at birth (49.50 ± 1.45 versus 48.97 ± 1.47 cm, P= 0.75) and head circumference at birth (34.23 ± 1.22 versus 33.88 ± 1.26 cm, P = 0.56). No neonatal anomaly was observed in the two groups. Conclusions: No significant differences were observed between the groups based on the neonatal outcome including neonatal anthropometric parameters and lack of congenital anomaly. Keywords: Ondansetron; Pregnancy; Vitamin B6; Morning Sickness; Hyperemesis Gravidarum
- 14 September 2016
- Published by Brieflands in Journal of Comprehensive Pediatrics
- Vol. 7 (4)
Open AccessComparing Neonatal Outcome Following the Use of Ondansetron versus Vitamin B6 in Pregnant Females with Morning Sickness: A Randomized Clinical Trial
Background: Pregnancy-related nausea and vomiting or morning sickness with an overall prevalence rate of 80% is commonly appeared at the eighth week and frequently disappeared in most pregnant females at the 16th week of gestation. The severe form of the condition named hyperemesis occurs in one per 200 to 300 pregnancies; it is accompanied by dehydration, electrolyte instability and nutritional deficits and needs medical interventions. Limited data are available on harmful effects of common antiemetic medications used within pregnancy on human neonates. Objectives: The current study aimed to compare the effects of ondansetron and vitamin B6 on neonatal outcome in pregnant females with pregnancy-related nausea and vomiting. Neonatal outcome included the probable difference in neonates’ gestational age, weight, height, head circumference and frequency of apparent congenital anomalies. Methods: This randomized double-blinded clinical trial was conducted on 188 primipara singleton pregnant females with pregnancy-related nausea and vomiting who referred to state healthcare centers of Zabol, Iran, in 2014. The pregnant females were randomly assigned to receive drug packages including ondansetron tablets (4 mg) or vitamin B6 tablets (40 mg) and patients were instructed to take one tablet twice daily. Females were followed up until delivery and neonatal outcomes including any congenital anomaly, weight, height and head circumference at birth were assessed. Results: There was no difference between the groups in the mean age of mother and the mean age of gestation. No differences were found between the groups regarding birth weight (3006.93 ± 441.86 versus 2949.65 ± 457.36 g, P= 0.67), height at birth (49.50 ± 1.45 versus 48.97 ± 1.47 cm, P= 0.75) and head circumference at birth (34.23 ± 1.22 versus 33.88 ± 1.26 cm, P = 0.56). No neonatal anomaly was observed in the two groups. Conclusions: No significant differences were observed between the groups based on the neonatal outcome including neonatal anthropometric parameters and lack of congenital anomaly. Keywords: Ondansetron; Pregnancy; Vitamin B6; Morning Sickness; Hyperemesis Gravidarum